Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups

Summary

This clinical trial implements research strategies to increase colorectal cancer (CRC) screening rates among low income and ethnic minority groups. CRC is the second most common cause of cancer mortality in the United States and disproportionately burdens low income and ethnic minority groups. Fecal immunochemical testing (FIT) is a test to check for blood in the stool. A brush is used to collect water drops from around the surface of a stool while it is still in the toilet bowl. The samples are then sent to a laboratory, where they are checked for a human blood protein. Blood in the stool may be a sign of colorectal cancer. Despite its potential for reducing CRC incidence and mortality, screening remains woefully underutilized. There is an unmet need for practical and effective programs to improve CRC screening rates. By implementing a culturally-tailored screening CRC program that supports providers and clinic staff to encourage eligible patients to complete FIT, researchers hope to reduce cancer disparities among low-income and ethnic groups and increase the CRC screening rate, which will help providers find CRC sooner, when it may be easier to treat.

Conditions

• Colorectal Carcinoma

Interventions

OTHER

Best Practice

Receive CRC screening usual care

OTHER

Consultation

Receive consultation with clinic staff

OTHER

Educational Intervention

Receive education and training on CRC screening

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Fecal Immunochemical Test

Receive FIT kit with culturally tailored instructions

BEHAVIORAL

Feedback

Receive feedback on CRC screening

BEHAVIORAL

Health Education

Receive CRC screening recommendations

OTHER

Support Education Activity

Utilize clinical decision support tool

OTHER

Text Message-Based Navigation Intervention

Receive text message reminders

Sponsors & Collaborators

• Tobacco Related Disease Research Program

  collaborator OTHER

• Jonsson Comprehensive Cancer Center

  lead OTHER

Principal Investigators

• Roshan Bastani · UCLA / Jonsson Comprehensive Cancer Center

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

50 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-11-01

Primary Completion

2026-11-01

Completion

2027-11-01

Countries

• United States

Study Locations